Satralizumab as An Add-on Treatment in Refractory Pediatric MOGAD: A Case Report (P12-8.002)

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000208464
Citations
1
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
0.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Satralizumab as An Add-on Treatment in Refractory Pediatric MOGAD: A Case Report (P12-8.002)

Yujuan Jiao, Qian Wang
1 citations
Neurology
Immunodeficiency and Autoimmune Disorders
0.80
article

Satralizumab as An Add-on Treatment in Refractory Pediatric MOGAD: A Case Report (P12-8.002)

Yujuan Jiao, Qian Wang
article en
1 citations

Abstract

No abstract available for this paper.
NeurologyVol. 104(7_Supplement_1)
Beijing Hua Xin Hospital (CN)
Zero hunger
Openalex Percentile: Top 30%
Immunodeficiency and Autoimmune Disorders
0.80
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Satralizumab as An Add-on Treatment in Refractory Pediatric MOGAD: A Case Report (P12-8.002) — Yujuan Jiao, Qian Wang · Neurology (2025) | TGRS Research Map | TGRS